The Effect of Henagliflozin and Metformin on Myocardial Tissue-level Characteristics

Clinical trial NCT06059287 · UNKNOWN

Trial details

NCT number: NCT06059287
Sponsor: RenJi Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Obesity Type 2 Diabetes Sodium-glucose Co-transporter-2 Inhibitor Myocardial Fibrosis Magnetic Resonance Imaging

Start date: 2023-10-01
Primary completion: 2025-12-31
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.